title: Stimulation of Na+/H+ exchange is not required for induction of hypertrophy of renal cells in vitro.
abstract: Hypertrophy of renal proximal tubular cells is associated with an early increase in Na+/H+ antiport activity both in vivo and in vitro. The purpose of the study presented here was to determine whether functioning Na+/H+ antiport activity is required for hypertrophy to occur. LLC-PK1 cells deficient in Na+/H+ antiport activity were prepared by the "proton-suicide" method. Mutant cells had 28 to 40% of the normal Na+/H+ antiport activity. The addition of 50 nM methylisobutylamiloride to these cells decreased the antiport activity to less than 5% of the control value. In the mutant cells, steady-state intracellular pH was normal as was the protein content. After exposure of the wild-type cells for 72 h to 10(-6) M insulin and 10(-9) M insulin-like growth factor 1, cell protein content increased significantly. The increase in protein content induced by these growth factors in the mutant cells did not differ significantly from the response of the wild-type cells. Lowering the Na+/H+ exchange further by the addition of methylisobutylamiloride (50 nM) to less than 5% of the control value did not blunt the hypertrophic response in the mutant cells. These studies indicate that hypertrophy can be induced in LLC-PK1 cells by growth factors when basal Na+/H+ antiport activity is reduced to low levels by selective mutation or by competitive inhibition. The results suggest that stimulation of the Na+/H+ antiporter is not an essential prerequisite for the induction of hypertrophy in renal cells.
authors.affiliation: Department of Medicine, UCLA Center for the Health Sciences.
authors.forename: M
authors.initials: M
authors.lastname: Mackovic-Basic
authors.forename: L G
authors.initials: LG
authors.lastname: Fine
authors.forename: J T
authors.initials: JT
authors.lastname: Norman
authors.forename: E J
authors.initials: EJ
authors.lastname: Cragoe
authors.forename: I
authors.initials: I
authors.lastname: Kurtz
mesh_terms: D000584:Amiloride / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D002021:Buffers; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism*; D016923:Cell Death; D002455:Cell Division / Q000187:drug effects; D048429:Cell Size / Q000187:drug effects; D002478:Cells, Cultured; D002712:Chlorides / Q000378:metabolism; D002794:Choline; D006863:Hydrogen-Ion Concentration; D007668:Kidney / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D008094:Lithium / Q000378:metabolism; D018021:Lithium Chloride; D011522:Protons; D012641:Selection, Genetic; D012964:Sodium / Q000378:metabolism*; D017923:Sodium-Hydrogen Exchangers; D013552:Swine
chemical_list: D002021:Buffers; D002352:Carrier Proteins; D002712:Chlorides; D011522:Protons; D017923:Sodium-Hydrogen Exchangers; D000584:Amiloride; C056369:5-(N-methyl-N-isobutyl)amiloride; D008094:Lithium; D012964:Sodium; D018021:Lithium Chloride; D002794:Choline